HIGHLIGHTS
- who: u00c9va Ru00e1ku00f3czi and collaborators from the Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary have published the research work: Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine, in the Journal: Diagnostics 2023, 13, 556. of 21/Dec/2022
- what: The study has certain strengths and limitations.
- how: When the authors studied the effect of age on these serology test results there were lower pre-booster levels in those who were older than 60 years of age compared to younger study participants in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.